Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mucci

Showing results (471-480 of 492) with videos related to

Pageof 50
Sort By:
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 27, 2024
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon EuropeB T Baune, S E Fromme, M Aberg, et al.
International Journal of Cancer|March 16, 2019
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studiesEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, et al.
American Journal of Epidemiology|June 4, 2019
The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort StudiesBing Yu, Krista A Zanetti, Marinella Temprosa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT StudyCharleen D Adams, Rebecca Richmond, Diana L Santos Ferreira, et al.
Journal of the National Cancer Institute|September 22, 2025
Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohortsElmira Ebrahimi, Sabine Naudin, Niki Dimou, et al.
Plos Medicine|May 20, 2025
Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North AmericaSabine Naudin, Molin Wang, Niki Dimou, et al.
Pageof 50

Showing results (471-480 of 492) with videos related to

Sort By:
Pageof 50
Cancers|November 7, 2020
The <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common AncestorAndreia Brandão, Paula Paulo, Sofia Maia, et al.
Prostate Cancer and Prostatic Diseases|January 9, 2021
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancerRoshan A Karunamuni, Minh-Phuong Huynh-Le, Chun C Fan, et al.
Nature Cancer|January 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS studyJason L Vassy, Anna M Dornisch, Roshan Karunamuni, et al.
European Archives of Psychiatry and Clinical Neuroscience|December 27, 2024
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon EuropeB T Baune, S E Fromme, M Aberg, et al.
International Journal of Cancer|March 16, 2019
The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF-I, IGF-II, IGFBP-1, IGFBP-2 and IGFBP-3 in a pooled analysis of 16,024 men from 22 studiesEleanor L Watts, Aurora Perez-Cornago, Paul N Appleby, et al.
American Journal of Epidemiology|June 4, 2019
The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort StudiesBing Yu, Krista A Zanetti, Marinella Temprosa, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Germline polygenic score for prostate cancer aggressivenessGeorge Jiajie Xu, Roshan Karunamuni, Anna M Dornisch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2018
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT StudyCharleen D Adams, Rebecca Richmond, Diana L Santos Ferreira, et al.
Journal of the National Cancer Institute|September 22, 2025
Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohortsElmira Ebrahimi, Sabine Naudin, Niki Dimou, et al.
Plos Medicine|May 20, 2025
Alcohol intake and pancreatic cancer risk: An analysis from 30 prospective studies across Asia, Australia, Europe, and North AmericaSabine Naudin, Molin Wang, Niki Dimou, et al.
Pageof 50